Impact of CNS treatment on mood in adult survivors of childhood leukemia: A report from the Children's Cancer Group

The Children's Hospital of Philadelphia, Filadelfia, Pennsylvania, United States
Journal of Clinical Oncology (Impact Factor: 18.43). 12/2003; 21(23):4395-401. DOI: 10.1200/JCO.2003.04.089
Source: PubMed


This study assessed the relationship between CNS treatment and psychologic mood using the Profile of Moods State (POMS), a standardized measure of affect, among a large sample of young adult survivors of childhood acute lymphoblastic leukemia (ALL; N = 555).
Survivors of childhood ALL (ages 18 to 33 years at study entry) participated in a structured telephone interview eliciting demographic, health, and behavioral data and the POMS. Treatment data included total dose of CNS irradiation (CRT) and intrathecal methotrexate (MTX) obtained from medical records.
Mood disturbance was reported by 24% of survivors. High-dose CRT and MTX predicted disturbance rates modestly and primarily in combination with education variables. Interactions between educational achievement, a history of attendance in special education classes, and sex were better predictors than treatment type or dose. Nonwhite males, those younger than 12.5 years of age at diagnosis, and those with negative perceptions of current health and cancer's impact on employment were also at greater risk for mood disturbance (P <.01 to.001).
Although most survivors are doing well psychologically, a subset of long-term survivors show potentially serious mood disturbance. Mood disturbance seems to be a function of interactions between preexisting individual difference variables (eg, sex, race/ethnicity), treatment factors, and posttreatment educational experiences. Prevention strategies aimed at childhood cancer survivors at greatest risk for mood disturbance may be improved by focus on posttreatment psychosocial and educational supports.

8 Reads
  • Source
    • "A tendency to avoid higher education has also been reported (Boman & Bodegard, 2004). Specifically, studies conducted with brain tumor survivors and others who have undergone central nervous system treatment show that these individuals tend to have poor social skills, problems with peer relationships, academic difficulties (which include issues with learning and concentrating), problems obtaining special education placements, and a reduced level of educational attainment and are less likely to enter college and to leave the family home (Barrera, Shaw, Speechley, Maunsell, & Pogany, 2005; Barr et al., 1999; Carlson-Green, Morris, & Krawiecki, 1995; de Boer et al., 2006; Glover et al., 2003; Koch et al., 2006; Koch, Kejs, Engholm, Johansen, & Schmiegelow, 2004; Langeveld, Stam, Grootenhuis, & Last, 2002; Mitby et al., 2003). A less frequent focus of the extant research on childhood cancer survivors has involved qualitative studies that invoke the stories of cancer as lived and told by young people and their families (Woodgate, 2005, 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Multimodal therapy for the treatment of childhood cancer has resulted in increased survival rates, yet as growing cohorts of children mature, late effects are becoming apparent. Specifically, brain tumor survivors tend to have poor social skills, peer relationship problems, academic difficulties, and delayed college entry. This article addresses findings specific to the unique experience of childhood cancer survivors as they transition from adolescence to adulthood. Qualitative methods involving focus groups and in-depth interviews with 14 childhood cancer survivors and 22 family members were used. The dialectic of incompetence/competence pervaded all narratives. Contradictory concepts of integration/ isolation, realistic/unrealistic goals, and the need for special help/no help were underscored by respondents. The struggle to deal with these contradictory factors led to the simultaneous resistance and acceptance of feelings of competence.
    Journal of Pediatric Oncology Nursing 03/2008; 25(3):164-74. DOI:10.1177/1043454208315547 · 0.90 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: With modern therapies, most children diagnosed with cancer are expected to reach adulthood. Therefore, there are large and ever-increasing numbers of children and young adults in our population who are survivors of childhood cancer. Many of the therapies responsible for improved cancer survival rates can also damage normal cells and tissues. As more children survive cancer, the physical and emotional costs of enduring cancer therapy become increasingly important. Although most childhood cancer survivors are now expected to survive, they remain at risk for relapse, second malignant neoplasms, organ dysfunction, and a negative psychologic impact. Individual risk is quite variable and is dependent on multiple factors including the type and site of cancer, the therapy utilized, and the individual’s constitution. The risks are likely to change as we learn more about the specific long-term effects of cancer therapy, develop more refined and targeted therapies, and develop and apply more effective preventative strategies or therapeutic interventions. Guidelines for long-term follow-up have been established and are available to help facilitate appropriate monitoring of and care for potential late effects.
    Paediatric Drugs 11/2002; 8(2). DOI:10.2165/00148581-200608020-00001 · 1.98 Impact Factor
  • Journal of Pediatric Hematology/Oncology 03/2004; 26(2):79-80. DOI:10.1097/00043426-200402000-00002 · 0.90 Impact Factor
Show more

Preview (2 Sources)

8 Reads
Available from